-

$undefined

N/A

(N/A)

Lumos Pharma NASDAQ:LUMO

Location: | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

24.02M

Cash

13.52M

Avg Qtr Burn

-7.918M

Short % of Float

1.58%

Insider Ownership

32.69%

Institutional Own.

24.27%

Qtr Updated

09/30/24

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
LUM-201 (Ibutamoren) Details Pediatric growth hormone deficiency	Phase 3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
LUM-201 (Ibutamoren) Details Turner syndrome	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.